Education
About Us
Working with TipRanks
Follow Us
Jounce Therapeutics (JNCE)
:JNCE
JNCE Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Jounce Therapeutics News
JNCE FAQ
What was Jounce Therapeutics’s price range in the past 12 months?
Currently, no data Available
What is Jounce Therapeutics’s market cap?
Currently, no data Available
When is Jounce Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Jounce Therapeutics’s earnings last quarter?
Currently, no data Available
Is Jounce Therapeutics overvalued?
According to Wall Street analysts Jounce Therapeutics’s price is currently Undervalued.
Does Jounce Therapeutics pay dividends?
Jounce Therapeutics does not currently pay dividends.
What is Jounce Therapeutics’s EPS estimate?
Jounce Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Jounce Therapeutics have?
Currently, no data Available
What happened to Jounce Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Jounce Therapeutics?
Currently, no hedge funds are holding shares in JNCE